| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 09/20/2007 | US20070219233 Substituted Indoles and Their Use as Integrin Antagonists |
| 09/20/2007 | US20070219232 Chemical Compounds |
| 09/20/2007 | US20070219231 Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof |
| 09/20/2007 | US20070219230 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof |
| 09/20/2007 | US20070219229 Pyrrolopyridine Derivatives |
| 09/20/2007 | US20070219228 Aryl substituted imidazonaphthyridines |
| 09/20/2007 | US20070219218 Compounds for the treatment of inflammatory disorders |
| 09/20/2007 | US20070219215 Thioamides and Salts Thereof and Cytokine Production Inhibitors Containing Both |
| 09/20/2007 | US20070219205 To treat autoimmune, inflammatory, proliferative, hyperproliferative,neurodegenerative or immunologically-mediated diseases; useful for the study of kinases in biological and pathological phenomena; study of intracellular signal transduction pathways mediated by such kinases, and comparative evaluation |
| 09/20/2007 | US20070219204 Pharmaceutically active ornitihine derivatives, ammonium salts thereof and methods of making same |
| 09/20/2007 | US20070219203 Arylalkylamino-substituted quinazoline analogues |
| 09/20/2007 | US20070219196 Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines |
| 09/20/2007 | US20070219188 Oxadiazine Derivatives |
| 09/20/2007 | CA2646516A1 Thiazoles as nf-kb inhibitors (proteasome inhibitors) |
| 09/20/2007 | CA2645711A1 Quinolone derivative or pharmaceutically acceptable salt thereof |
| 09/20/2007 | CA2645062A1 Spiroindolinone derivatives |
| 09/20/2007 | CA2644758A1 Spiroindolinone derivatives |
| 09/20/2007 | CA2644033A1 Heterobicyclic carboxamides as inhibitors for kinases |
| 09/20/2007 | CA2643962A1 Antibiotic compounds |
| 09/19/2007 | EP1834954A1 Thiazoles as NF-kB Inhibitors (proteasome inhibitors) |
| 09/19/2007 | EP1833833A2 Polymorphs of 1-(2-methylpropyl)-1h-imidazo 4,5-c 1,5 naphthyridin-4-amine ethanesulfonate |
| 09/19/2007 | EP1833832A1 Napthyridine compounds as rock inhibitors |
| 09/19/2007 | EP1833831A1 Substituted heterocyclic compounds and methods of use |
| 09/19/2007 | EP1833830A1 Quinoline derivative, use and production thereof, and drug containing the same |
| 09/19/2007 | EP1833829A2 Benzamide substituted imidazo- and pyrrolo-pyridines as protein kinase inhibitors |
| 09/19/2007 | EP1833828A2 Condensed pyridines as kinase inhibitors |
| 09/19/2007 | EP1833827A2 Process for preparing 2-methyl-1-(2-methylpropyl)-1h-imidazoý4,5-c¨ý1,5¨naphthyridin-4-amine |
| 09/19/2007 | EP1833816A1 Substituted piperidines as renin inhibitors |
| 09/19/2007 | EP1833479A2 1-(2-methylpropyl)-1h-imidazo 4,5-c(1,5 )naphthyridin-4-amine ethanesulfonate and 1-(2-methylpropyl)-1h-imidazoý4,5-c 1,5 naphthyridin-4-amine methanesulfonate |
| 09/19/2007 | EP1833477A1 Pyrazolo-heteroaryl compounds useful to treat tnf-alpha and il-1 mediated diseases |
| 09/19/2007 | EP1749004B1 Pyrrolyl substituted pyrido[2,3-d]pyrimidin-7-ones and derivatives thereof as therapeutic agents |
| 09/19/2007 | EP1680426B1 1.3.4-triaza-phenalene and 1,3,4,6-tetraazaphenalene derivatives |
| 09/19/2007 | EP1622867B1 N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists |
| 09/19/2007 | EP1539115B1 Methods and dosage forms for controlled delivery of paliperidone |
| 09/19/2007 | EP1519934B1 Pyrazoloisoquinoline derivatives for inhibiting nf$g(k)b-inducing kinase (nik) |
| 09/19/2007 | EP1439841B1 Androgen receptor modulators and methods of use thereof |
| 09/19/2007 | EP1309590B1 Azaindole derivatives, process for their preparation, and their use as antitumor agents |
| 09/19/2007 | EP1296982B1 1-(heteroaryl-phenyl)-condensed pyrazol derivatives as factor xa inhibitors |
| 09/19/2007 | CN101039947A Inhibitors of hcv replication |
| 09/19/2007 | CN101039944A 1,5-naphthyridine azolidinones having cdk1 antiproliferative activity |
| 09/19/2007 | CN101039943A Novel azaindole thiazolinones as anti-cancer agents |
| 09/19/2007 | CN101039942A Sulfonamides and uses thereof |
| 09/19/2007 | CN101039932A Heterocyclic substituted bisarylurea derivatives as kinase inhibitors |
| 09/19/2007 | CN101039908A Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 09/19/2007 | CN101037438A Compositions useful as inhibitors of GSK-3 |
| 09/19/2007 | CN101037437A Flazin analog and preparation method and application thereof |
| 09/19/2007 | CN100338074C Heterocyclic compounds and cerebral function improvers containing same as active |
| 09/19/2007 | CN100338063C 7-phenylpyrazolopyridine compounds |
| 09/19/2007 | CN100338062C Azaindoles as inhibitors of c-Jun N-terminal kinases |
| 09/19/2007 | CN100338061C Alkyne-aryl phosphodiesterase-4 inhibitors |
| 09/19/2007 | CN100338050C Amine acid salt compounds and process for the production thereof |
| 09/19/2007 | CN100338044C HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 09/19/2007 | CN100338040C Xanthine oxidase inhibitors |
| 09/18/2007 | US7271270 High affinity small molecule C5a receptor modulators |
| 09/18/2007 | US7271265 Cyanine compounds and their application as quenching compounds |
| 09/18/2007 | US7271261 Useful as adjuvants to chemotherapy or radiation therapy in the treatment of cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2) |
| 09/18/2007 | US7271178 Heterocyclic inhibitors of MEK and methods of use thereof |
| 09/18/2007 | US7271176 heterocylic amines such as 2-(5-{3-[4-(4-Chloro-2-methyl-phenyl)-piperazin-1-yl]-propylidene}-5,11-dihydro-10-oxa-1-aza-dibenzo[a,d]cyclohepten-7-yl)-propan-2-ol, used for treating diseases associated with aberrant leukocyte recruitment and/or activation |
| 09/18/2007 | US7271172 Pyrrolidine and azetidine compounds as CCR5 antagonists |
| 09/18/2007 | US7271171 Adenosine A3 receptor modulators |
| 09/18/2007 | US7271159 Camptothecin analogs and methods of preparation thereof |
| 09/18/2007 | US7270893 Organic electroluminescent element and display |
| 09/13/2007 | WO2007103719A2 MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| 09/13/2007 | WO2007102580A1 Polycyclic cinnamide derivative |
| 09/13/2007 | WO2007102059A1 Sulfonyl benzimidazole derivatives |
| 09/13/2007 | WO2007101369A1 Preparation method and use of compounds having high biocidal activities |
| 09/13/2007 | WO2007087283A3 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 09/13/2007 | WO2006121528A3 Ring closing and related methods and intermediates |
| 09/13/2007 | WO2005089764A9 Carboline derivatives useful in the inhibition of angiogenesis |
| 09/13/2007 | WO2005058894A8 Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives |
| 09/13/2007 | US20070213537 Hydrogenating a heteroaryl alpha-hydroxyacetamide in a solvent comtaining a strong acid, a halide and a precious metal catalyst; molar ratio of the starting heteroaryl alpha-hydroxyacetamide to water at the initiation of hydrogenolysis of at least 2:1; preparing zolpidem from alpha-hydroxyzolpidem. |
| 09/13/2007 | US20070213536 Process for the enantiomeric enrichment of cis-8-benzyl-7,9-dioxo-2,8-diazabicyclo[4.3.0]nonane |
| 09/13/2007 | US20070213362 2-nh-heteroarylimidazoles with antibacterial activity |
| 09/13/2007 | US20070213361 Preventive and/or therapeutic agent for neutrophilic inflammatory diseases |
| 09/13/2007 | US20070213359 Bicyclic-nitrogen compounds as modulators of ghrelin receptor and uses thereof |
| 09/13/2007 | US20070213358 1-(4-chlorobenzyl)-7-(1,2,3,4-tetrahydroisoquinolin-2-yl)-2,3-dimethyl-1H-pyrrolo[3,2-b]pyridine hydrochloride; proton pump inhibition effects and possess the ability to attain a reversible proton pump inhibitory effect; inhibitory activity against gastric acid secretion |
| 09/13/2007 | US20070213356 Nitrogen-Containing Heterocyclyl Substituted Imidazoquinolines and Imidazonaphthyridines |
| 09/13/2007 | US20070213355 1H-Imidazo[4,5-C]Quinoline Derivatives in the Treatment of Protein Kinase Dependent Diseases |
| 09/13/2007 | US20070213341 Spiroindolinone derivatives |
| 09/13/2007 | US20070213338 Triazolo-Pyridazine Compounds and Derivatives Thereof Useful in the Treatment of Neuropathic Pain |
| 09/13/2007 | US20070213337 Modulators of serotonin receptors |
| 09/13/2007 | US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
| 09/13/2007 | US20070213332 Prodrugs Of Substituted Amino Heterobicycles Which Modulate The Function Of The Vanilloid-1 Receptor (Vr1) |
| 09/13/2007 | US20070213327 Inhibitors of Src family protein kinases; autoimmune, inflammatory, proliferative, or hyperproliferative, immunologically-mediated disease, or bone disease; 1-Cyclopentyl-3-(4-phenoxyphenyl)-1H-pyrrolo[3,2-c]pyridin-4-amine |
| 09/13/2007 | US20070213320 4-substituted-1,5-dihydro-pyrido[3,2-b]indol-2-ones |
| 09/13/2007 | US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/13/2007 | DE102006011269A1 Persistente Perylenbisimid-Radikalanionen als NIR-Farbstoffe Persistent perylene bisimide radical as NIR dyes |
| 09/13/2007 | CA2645137A1 Heterobicyclic pyrazole compounds and methods of use |
| 09/13/2007 | CA2643796A1 Polycyclic cinnamide derivatives |
| 09/12/2007 | EP1832590A2 Tri- heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 09/12/2007 | EP1832587A1 Method for preparing moxifloxacin and moxifloxacin hydrochloride |
| 09/12/2007 | EP1832287A2 The use of anti-histaminics for acute reduction of elevated intracranial pressure |
| 09/12/2007 | EP1831227A2 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders |
| 09/12/2007 | EP1831226A2 CHIRAL FUSED 1,2 IMIDAZO 4,5-c RING COMPOUNDS |
| 09/12/2007 | EP1831222A1 Novel spirotropane compounds and methods for the modulation of chemokine receptor activity |
| 09/12/2007 | EP1831221A2 Substituted chiral fused 1,2 imidazo 4,5-c ring compounds |
| 09/12/2007 | EP1831220A2 Processes for the preparation of 3,4-substituted-1,2,5-thiadiazoles and intermediates thereof |
| 09/12/2007 | EP1831219A2 A process for the preparation of substantially pure 4-amino-1-isobutyl-1h-imidazoý4,5-c¨-quinoline (imiquimod) |
| 09/12/2007 | EP1831218A2 Carbamate substituted imidazo- and pyrrolo-pyridines as protein kinase inhibitors |
| 09/12/2007 | EP1831217A2 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment |